Isolere Bio

Developer of bioprocessing reagents for purification and manufacturing of therapeutics

placeDurham, North Carolina, United States calendar_todayFounded 2017 groups18 employees language isolerebio.com

Innovation

6 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 194 times.

YearFilings
20201
20213
20224
20235
20241

Social engagement

Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Northpond Ventures.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%

Recent activity

13 May 2026
Event
ASGCT2026
13 May 2026
Event
ASGCT2026
12 May 2026
Event
ASGCT2026
Coming soon